Vivos Therapeutics Reports that Supported Professional Practices Have Achieved 'In-Network' Status Across Multiple Commercial Health Insurers and Medicare in Key Nevada Market

Core Insights - Vivos Therapeutics has achieved 'in-network' status with several major health insurance payers in Nevada, enhancing patient access to its obstructive sleep apnea (OSA) treatments and potentially increasing revenue and profitability [1][2][3][4] - The company is implementing cost reduction initiatives aimed at its legacy business model, which are expected to save approximately $4 million annually, thereby reducing cash burn and moving towards cash flow positivity in fiscal year 2026 [5][12] Insurance Coverage - Vivos' physician-owned practices in Nevada have gained 'in-network' status with multiple health insurance providers, including Medicare, UnitedHealthcare, and Aetna, which cover a significant portion of the Las Vegas metropolitan area population [3][4] - This development is anticipated to improve patient access to Vivos' patented OSA treatments, allowing previously evaluated patients to be contacted regarding insurance coverage availability [4] Cost Reduction Initiatives - The company has initiated a series of cost reduction measures, including workforce reduction and restructuring vendor relationships, to streamline operations related to its legacy dental-focused distribution model [5] - These initiatives are projected to yield around $4 million in annual savings, which will help in reducing the company's cash burn rate [5][12] Market Context - OSA affects over 1 billion people globally, with a significant portion remaining undiagnosed, highlighting the ongoing need for effective treatment solutions [8] - Vivos aims to address the complexities of OSA treatment through innovative technology and collaborations with healthcare providers, moving away from traditional CPAP treatments [9][10]